Prognostic score of hyperlactatemia under ART
Journal Title: Terapeutica, Farmacologie si Toxicologie Clinica - Year 2008, Vol 12, Issue 1
Abstract
Background: mitochondrial toxicity is an adverse event of nucleoside reverstranscriptase inhibitors. The biochemical marker is the increased level of serum lactate. Objectives: to identify the risk factors for hyperlactatemia and to establish a prognostic score. Methods: we prospectively studied 49 adults under ART. Lactate level and other parameters were studied. Univariate and multivariate statistics were used. Results: risk factors for hyperlactatemia are: age over 40 and hemoglobin under 11g%. The result of prognostic score was 0.5. Conclusions: a good prognosis means a score under 0.5. The score might be a replacement method for the lactate concentration
Authors and Affiliations
Corina Itu, C. Jianu, Doina Ţăţulescu, Mirela Flonta, Ligia Ursu, Virginia Zanc, D. Cârstina
Keywords
Related Articles
- EP ID EP83076
- DOI -
- Views 107
- Downloads 0
Quantum medicine
BRT is the therapy with electromagnetic oscillations, structures of the organism come into resonance with them. The influence is possible on cellular level as at the level of organ, system of organs and whole body. The...
Blood culture - actual requirements and perspectives
The detection of bloodstream infections (BSI) is one of the most important tasks performed in clinical microbiology laboratory. Rapid and reliable detection of BSI includes identification of pathogens at species level an...
Strontium - clinical and paraclinical aspects
[b]Introduction:[/b] Stable Strontium -meaning nonradioactive- is nontoxic, even when administered in large doses for prolonged periods. It also appears to be one of the most effective substances yet found for the preven...
Prognostic score of hyperlactatemia under ART
Background: mitochondrial toxicity is an adverse event of nucleoside reverstranscriptase inhibitors. The biochemical marker is the increased level of serum lactate. Objectives: to identify the risk factors for hyperlacta...
Statins in the treatment of atherogenic dislipidemia
Statins are the most usefull drugs in the treatment of atherogenic dislipidemia. The benefit of statins was demonstrated in primary and secondary prevention of cardiovascular disease and consists in reduction of major ca...